How a Company Makes Millions Off a Hospital Program Meant to Help the Poor
New York Times
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
https://www.nytimes.com/2025/01/15/us/340b-apexus-drugs-middleman.html